Literature DB >> 19737278

Prostate cancer: a newly discovered route for testosterone to reach the prostate : Treatment by super-selective intraprostatic androgen deprivation.

Y Gat1, S Joshua, M G Gornish.   

Abstract

The prostate, an androgen-regulated exocrine gland, is an integral part of the male reproductive system which has an essential function in sperm survival and motility in its long hostile route to meet and fertilise the egg in the Fallopian tube. Testosterone is known to be the key, obligatory regulator of the prostate that promotes the development and progression of prostate cancer (PCa). Yet, the pathophysiological mechanism of PCa remains unclear and its causal relation to serum testosterone has not been established. Here, we report on the discovery of a previously unrecognized route of flow of free testosterone (FT), at a concentration of 130 times the physiological levels, reaching the prostate via the testicular and prostate venous drainage systems, bypassing the systemic circulation. This condition results from the malfunction of the vertically oriented testicular venous drainage system in humans, a phenomenon with a prevalence that increases rapidly with age, which causes deviation of the testicular venous flow from its normal route. Early results of an interventional radiological procedure, super-selective intraprostatic androgen deprivation therapy are discussed. This treatment has resulted in decrease in prostate volume, and serum PSA, with disappearance of cancerous cells on repeat biopsies in five of six patients. Some of the unresolved biological enigmatic questions associated with PCa are discussed. We conclude that pathological flow of FT from the testes directly to the prostate in an extremely high concentration via the testicular-prostate venous drainage systems was identified may explain the mechanism for the development of PCa. We suggest a time-window for eradication of localised, androgen-sensitive, PCa cells. We anticipate that this treatment may retard, stop or even reverse the development of the disease. A mechanism for the evolution of PCa is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737278     DOI: 10.1111/j.1439-0272.2009.00972.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  4 in total

1.  Total testosterone in young men is more closely associated than free testosterone with prostate cancer disparities.

Authors:  Louis Calistro Alvarado
Journal:  Ther Adv Urol       Date:  2011-06

2.  Childhood height increases the risk of prostate cancer mortality.

Authors:  J Aarestrup; M Gamborg; M B Cook; J L Baker
Journal:  Eur J Cancer       Date:  2015-04-17       Impact factor: 9.162

Review 3.  Testosterone Replacement Therapy on the Natural History of Prostate Disease.

Authors:  Aaron Moore; Michael J Butcher; Tobias S Köhler
Journal:  Curr Urol Rep       Date:  2015-08       Impact factor: 3.092

4.  Paying the price for standing tall: Fluid mechanics of prostate pathology.

Authors:  Yigal Gat; Sharon Joshua; Stanimir Vuk-Pavlović; Menachem Goren
Journal:  Prostate       Date:  2020-08-24       Impact factor: 4.104

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.